Programmed cell death protein blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation in an adolescent patient

Irtiza Sheikh; Cesar Nunez; David McCall; Michael Roth; Branko Cuglievan

doi:10.1002/pbc.29390

Programmed cell death protein blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation in an adolescent patient

Irtiza Sheikh, Cesar Nunez, David McCall, Michael Roth, Branko Cuglievan

Pediatrics

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English (US)
Article number	e29390
Journal	Pediatric Blood and Cancer
Volume	69
Issue number	3
DOIs	https://doi.org/10.1002/pbc.29390
State	Published - Mar 2022

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Hematology
Oncology

Access to Document

10.1002/pbc.29390

Cite this

@article{17fabf521fc9495781f4dea23d07a2b9,

title = "Programmed cell death protein blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation in an adolescent patient",

author = "Irtiza Sheikh and Cesar Nunez and David McCall and Michael Roth and Branko Cuglievan",

year = "2022",

month = mar,

doi = "10.1002/pbc.29390",

language = "English (US)",

volume = "69",

journal = "Pediatric Blood and Cancer",

issn = "1545-5009",

publisher = "Wiley-Liss Inc.",

number = "3",

}

TY - JOUR

T1 - Programmed cell death protein blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation in an adolescent patient

AU - Sheikh, Irtiza

AU - Nunez, Cesar

AU - McCall, David

AU - Roth, Michael

AU - Cuglievan, Branko

PY - 2022/3

Y1 - 2022/3

UR - http://www.scopus.com/inward/record.url?scp=85123505939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85123505939&partnerID=8YFLogxK

U2 - 10.1002/pbc.29390

DO - 10.1002/pbc.29390

M3 - Letter

C2 - 35077016

AN - SCOPUS:85123505939

SN - 1545-5009

VL - 69

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

IS - 3

M1 - e29390

ER -

Programmed cell death protein blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation in an adolescent patient

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this